Dianthus Therapeutics, Inc.
- Stock
- Ticker DNTH
- ISIN US2528281080
- Nasdaq
Performance, volatility and drawdowns of Dianthus Therapeutics, Inc. since 09/2023, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $75,626. Global equities (VT): $15,235.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −53.5% in 04/2025, measured from the peak in 03/2024. It took 18 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 1.3 | 1.2 | 0.2 | 0.4 | 0.3 | – | – | – |
| Operating income | -32 | -33 | -35 | -40 | -70 | -47 | -61 | -58 |
| EBITDA | -32 | -33 | -35 | -40 | -70 | -47 | -61 | -58 |
| Net income | -28 | -30 | -32 | -37 | -64 | -41 | -50 | -47 |
| Earnings per share | -0.82 | -0.82 | -0.88 | -0.97 | -1.52 | -0.85 | -0.90 | -0.81 |
| Balance sheet | ||||||||
| Total assets | 374 | 349 | 326 | 577 | 531 | 1,247 | 1,213 | 1,276 |
| Liabilities | 22 | 20 | 23 | 31 | 38 | 46 | 41 | 35 |
| Equity | 352 | 329 | 303 | 546 | 493 | 1,201 | 1,172 | 1,241 |
| Cash | 23 | 10 | 13 | 56 | 51 | 628 | 111 | 56 |
| Cash flow | ||||||||
| Operating cash flow | -27 | -28 | -24 | -31 | -47 | -29 | -49 | -50 |
| Free cash flow | -27 | -28 | -24 | -31 | -47 | -29 | -49 | -50 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2024 at +109.6%, weakest 2025 at +89.0%. 2 of 2 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | −$0.81 |
| 4 Aug 2026 | −$0.90 |
| 5 May 2026 | −$0.85 |
| 9 Mar 2026 | −$1.52 |
| 5 Nov 2025 | −$0.97 |
| 7 Aug 2025 | −$0.88 |
| 12 May 2025 | −$0.82 |
| 11 Mar 2025 | −$0.82 |
| 7 Nov 2024 | −$0.74 |
| 8 Aug 2024 | −$0.51 |
| 9 May 2024 | −$0.54 |
| 21 Mar 2024 | $8.95 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €4.3bn
- Market cap in trading currency
- $4.76bn
- Enterprise value
- $3.92bn
- P/E
- –
- P/S
- –
- P/B
- 3.84
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -3.7%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$236m
- Net income
- −$202m
- Earnings per share
- −$4.08
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- -22.6%
- Return on assets
- -15.8%
Balance sheet and cash flow
- Cash
- $838m
- Cash per share
- $14.88
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 30.02
- Book value per share
- $22.05
- Operating cash flow
- −$175m
- Free cash flow
- −$175m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 56.3m
- Volume
- 772,242
- Avg. volume 3 months
- 847,371
- Relative volume
- 0.9
Price and technicals
- Price
- $84.55
- 1 day
- −0.3%
- 52-week high
- $115.96
- 52-week low
- $36.20
- Distance to 52-week high
- −27.1%
- Distance to 52-week low
- +133.6%
- Distance to 50-day line
- −2.1%
- Distance to 200-day line
- −3.7%
- RSI (14)
- 47
- Volatility 1M
- 39.9%
Performance
- 1 week
- −7.9%
- 1 month
- +7.7%
- 3 months
- −23.2%
- 6 months
- −2.2%
- YTD
- +105.2%
- 1 year
- +107.3%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has DNTH performed since 09/2023?
$10,000 grew to $76,864 by 20 Nov 2026, which is +89.5% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is DNTH?
Volatility was 79.0% per year, measured on monthly returns. The largest decline from a peak was −53.5%, with the low in 04/2025.
How does DNTH compare with a broad equity ETF?
Over the same period Global equities (VT) returned +14.9% per year at 12.9% volatility, DNTH returned +89.5% at 79.0%. The correlation of monthly returns was 0.00; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.